European Patent Office

T 2003/08 (Dilated cardiomyopathy/EDWARDS) du 31.10.2012

Identifiant européen de la jurisprudence
ECLI:EP:BA:2012:T200308.20121031
Date de la décision
31 octobre 2012
Numéro de l'affaire
T 2003/08
Requête en révision de
-
Numéro de la demande
96941378.0
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents des chambres de recours (C)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
T 2003/08 2012-03-30
Résumés pour cette décision
-
Titre de la demande
Treatment of dilated cardiomyopathy by removal of autoantibodies
Nom du demandeur
Edwards Lifesciences Corporation
Reinke, Petra
Brehme, Stefan
Baumann, Gert
Felix, Stephan
Nom de l'opposant
Fresenius Medical Care Deutschland GmbH
Chambre
3.3.04
Sommaire
-
Mots-clés
"Request not to hear a witness due to failure to reply to the invitation in accordance with Rule 118(c) EPC (refused)";
"Request for referral of questions to the Enlarged Board of Appeal (refused)";
Main request: added subject-matter (yes)
Auxiliary request: claims to be interpreted as relating to a second medical use (yes) - means used in the treatment to be considered as a substance or composition in the sense of decision G 5/83; oral disclosure at a lecture - evidence from the lecturer and a member of the audience may be sufficient to establish the oral disclosure - contrary to the application by the first instance of decision T 1212/97; oral disclosure and prior use - established beyond reasonable doubt (no); conformity of the claims with the requirements of the EPC (yes)
Exergue
see points 6 to 21 and 30 to 48

ORDER

For these reasons it is decided that:

The appeals of both appellants are dismissed.